<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kurkinen ST</submitter><funding>Terveyden Tutkimuksen Toimikunta</funding><funding>Suomen Kulttuurirahasto</funding><funding>Biocenter Finland</funding><pagination>1100-1112</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8889583</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(4)</volume><pubmed_abstract>Molecular docking is a key in silico method used routinely in modern drug discovery projects. Although docking provides high-quality ligand binding predictions, it regularly fails to separate the active compounds from the inactive ones. In negative image-based rescoring (R-NiB), the shape/electrostatic potential (ESP) of docking poses is compared to the negative image of the protein's ligand binding cavity. While R-NiB often improves the docking yield considerably, the cavity-based models do not reach their full potential without expert editing. Accordingly, a greedy search-driven methodology, brute force negative image-based optimization (BR-NiB), is presented for optimizing the models via iterative editing and benchmarking. Thorough and unbiased training, testing and stringent validation with a multitude of drug targets, and alternative docking software show that BR-NiB ensures excellent docking efficacy. BR-NiB can be considered as a new type of shape-focused pharmacophore modeling, where the optimized models contain only the most vital cavity information needed for effectively filtering docked actives from the inactive or decoy compounds. Finally, the BR-NiB code for performing the automated optimization is provided free-of-charge under MIT license via GitHub (https://github.com/jvlehtonen/brutenib) for boosting the success rates of docking-based virtual screening campaigns.</pubmed_abstract><journal>Journal of chemical information and modeling</journal><pubmed_title>Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening.</pubmed_title><pmcid>PMC8889583</pmcid><funding_grant_id>337530</funding_grant_id><funding_grant_id>00190581</funding_grant_id><pubmed_authors>Lehtonen JV</pubmed_authors><pubmed_authors>Pentikainen OT</pubmed_authors><pubmed_authors>Postila PA</pubmed_authors><pubmed_authors>Kurkinen ST</pubmed_authors></additional><is_claimable>false</is_claimable><name>Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening.</name><description>Molecular docking is a key in silico method used routinely in modern drug discovery projects. Although docking provides high-quality ligand binding predictions, it regularly fails to separate the active compounds from the inactive ones. In negative image-based rescoring (R-NiB), the shape/electrostatic potential (ESP) of docking poses is compared to the negative image of the protein's ligand binding cavity. While R-NiB often improves the docking yield considerably, the cavity-based models do not reach their full potential without expert editing. Accordingly, a greedy search-driven methodology, brute force negative image-based optimization (BR-NiB), is presented for optimizing the models via iterative editing and benchmarking. Thorough and unbiased training, testing and stringent validation with a multitude of drug targets, and alternative docking software show that BR-NiB ensures excellent docking efficacy. BR-NiB can be considered as a new type of shape-focused pharmacophore modeling, where the optimized models contain only the most vital cavity information needed for effectively filtering docked actives from the inactive or decoy compounds. Finally, the BR-NiB code for performing the automated optimization is provided free-of-charge under MIT license via GitHub (https://github.com/jvlehtonen/brutenib) for boosting the success rates of docking-based virtual screening campaigns.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2024-11-12T06:28:35.347Z</modification><creation>2024-11-12T06:28:35.347Z</creation></dates><accession>S-EPMC8889583</accession><cross_references><pubmed>35133138</pubmed><doi>10.1021/acs.jcim.1c01145</doi></cross_references></HashMap>